Harding J M, Modell M, Freudenberg S, MacGregor R, Rea J N, Steen C A, Wojciechowski M, Yudkin G D
Br Med J (Clin Res Ed). 1985 Feb 9;290(6466):450-3. doi: 10.1136/bmj.290.6466.450.
This paper discusses drawing up a restricted list of 245 drugs for use in an inner London group practice, based on a review of prescribing patterns in November 1982. The likely impact of the recent proposals by the Department of Health and Social Security to limit drugs available for prescription under the National Health Service on this project and on patient care is considered. We conclude that generic prescribing and a limited list of drugs may improve the quality of prescribing and be the only way to curb prescribing costs but that a limited list should be flexible, responsive to patients' needs, and applied to all prescribing. There should also be a mechanism for consumer feedback and regular revision of the list.
本文基于对1982年11月处方模式的回顾，讨论了为伦敦市中心一个团体医疗诊所制定一份包含245种药物的受限清单。文中考虑了卫生与社会保障部近期关于限制国民医疗服务体系下可用于处方的药物的提议对该项目及患者护理可能产生的影响。我们得出结论，采用通用名开处方和一份受限的药物清单可能会提高处方质量，并且是控制处方成本的唯一途径，但受限清单应具有灵活性，能响应患者需求，并适用于所有处方。还应有一个消费者反馈机制以及对清单进行定期修订。
